Prognostic factors in prostate cancer
2006

Prognostic Factors in Prostate Cancer

Sample size: 567 publication 10 minutes Evidence: moderate

Author Information

Author(s): Buhmeida A, Pyrhönen S, Laato M, Collan Y

Primary Institution: Turku University Hospital, Turku, Finland

Hypothesis

What are the histological, cell biological and molecular features which could differentiate between aggressive and non-aggressive types of prostate cancer?

Conclusion

Gleason score, capsular invasion, blood PSA, stage, and aneuploidy are the best markers of progression in organ confined disease.

Supporting Evidence

  • Gleason score is a significant predictor of patient outcome.
  • Capsular invasion is associated with higher progression rates.
  • Blood PSA levels are important for predicting cancer progression.
  • Aneuploidy is linked to aggressive cancer behavior.
  • Age and race may influence survival outcomes in prostate cancer.

Takeaway

Doctors want to know which prostate cancers are serious and which are not. This study helps them figure that out by looking at different factors.

Methodology

This review analyzed various prognostic factors associated with prostate cancer based on published studies from 1989 to 2005.

Limitations

The review is based on existing literature, which may not cover all recent findings or advancements in prostate cancer research.

Participant Demographics

The study included male patients diagnosed with prostate cancer, with a focus on those undergoing radical prostatectomy.

Statistical Information

P-Value

< 0.0001

Digital Object Identifier (DOI)

10.1186/1746-1596-1-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication